Icon Bioscience's Melphalan Intraocular Injection Granted U.S. Orphan Drug Designation for the Treatment of Retinoblastoma
1/3/2013 9:00:32 AM
More...
|
Icon Bioscience Appoints Murahashi Vice President, Clinical Development
12/7/2011 10:54:45 AM
More...
|
Icon Bioscience Initiates Phase 2/3 Pivotal Clinical Study of Novel Ophthalmic Drug Candidate
1/5/2010 11:33:47 AM
More...
|
Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
8/5/2008 8:52:46 AM
More...
|